Price is also preparing to confront a slew of questions about potential conflicts of interest and his past financial investments. He has been criticized for investing in health companies while pursuing legislation that could influence those very firms. CNN reported Monday Price purchased shares in a medical device manufacturer last year, just days before introducing legislation that would have directly benefited the company.   As Price prepares for potentially contentious hearings, a transition official emphasized that the team is not taking anything for granted ahead of his confirmation. 